Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Tall

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Journal of Clinical Lipidology|November 16, 2010
Functions of cholesterol ester transfer protein and relationship to coronary artery disease riskAlan R Tall
The New England Journal of Medicine|March 24, 2006
Protease variants, LDL, and coronary heart diseaseAlan R Tall
Clinical Chemistry|November 22, 2020
HDL in Morbidity and Mortality: A 40+ Year PerspectiveAlan R Tall
The New England Journal of Medicine|April 9, 2004
C-reactive protein reassessedAlan R Tall
Circulation Research|February 28, 2002
MIghty mouseAlan R Tall
The New England Journal of Medicine|November 8, 2002
Exercise to reduce cardiovascular risk--how much is enough?Alan R Tall
The American Journal of Cardiology|November 10, 2009
The effects of cholesterol ester transfer protein inhibition on cholesterol effluxAlan R Tall
Arteriosclerosis, Thrombosis, and Vascular Biology|May 13, 2003
Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transportAlan R Tall
Atherosclerosis|July 21, 2018
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammationAlan R Tall
The New England Journal of Medicine|July 21, 2017
Increasing Lipolysis and Reducing AtherosclerosisAlan R Tall
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Journal of Clinical Lipidology|November 16, 2010
Functions of cholesterol ester transfer protein and relationship to coronary artery disease riskAlan R Tall
The New England Journal of Medicine|March 24, 2006
Protease variants, LDL, and coronary heart diseaseAlan R Tall
Clinical Chemistry|November 22, 2020
HDL in Morbidity and Mortality: A 40+ Year PerspectiveAlan R Tall
The New England Journal of Medicine|April 9, 2004
C-reactive protein reassessedAlan R Tall
Circulation Research|February 28, 2002
MIghty mouseAlan R Tall
The New England Journal of Medicine|November 8, 2002
Exercise to reduce cardiovascular risk--how much is enough?Alan R Tall
The American Journal of Cardiology|November 10, 2009
The effects of cholesterol ester transfer protein inhibition on cholesterol effluxAlan R Tall
Arteriosclerosis, Thrombosis, and Vascular Biology|May 13, 2003
Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transportAlan R Tall
Atherosclerosis|July 21, 2018
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammationAlan R Tall
The New England Journal of Medicine|July 21, 2017
Increasing Lipolysis and Reducing AtherosclerosisAlan R Tall
Pageof 20